{
	"kihkdannText": "Brintellix<span class=\"_ _1\"></span>®<span class=\"_ _4\"></span> consistent<span class=\"_ _4\"></span>ly improv<span class=\"_ _1\"></span>es cognitiv<span class=\"_ _1\"></span>e<span class=\"_ _4\"></span> <br><span class=\"ls0 ws0\">sympto<span class=\"_ _1\"></span>ms, su<span class=\"_ _1\"></span>ch as e<span class=\"_ _1\"></span>x<span class=\"_ _1\"></span>ecutiv<span class=\"_ _1\"></span>e fun<span class=\"_ _0\"></span>c<span class=\"_ _4\"></span>tio<span class=\"_ _1\"></span>n, attenti<span class=\"_ _1\"></span>on, <br><span class=\"ls14 ws1c\">speed of processing<span class=\"_ _4\"></span> and working memor<span class=\"_ _6\"></span>y in MDD*<span class=\"_ _1\"></span><span class=\"fs3 ls5c ws82 v1\">1<span class=\"_ _4\"></span>-7</span></span></span>",
	"kihkdanoText": "DSST",
	"kihkdanpText": "Study Design",
	"kihkdanqText": "MDD",
	"kihkdaocText": "Brintellix® has a ",
	"kihkdaodText": "clinically relevant",
	"kihkdaoeText": "effect <span class=\"_ _1\"></span><span class=\"ff3\">(Cohen’<span class=\"_ _0\"></span>s </span>",
	"kihkdaofText": "d &gt; 0.2) on cognitive",
	"kihkdaogText": "performance as ",
	"kihkdaohText": "measured by ",
	"kihkdaoiText": "DSST<span class=\"fs23 ls5f v7\">3–9</span>",
	"kihkdaokText": "PDQ<span class=\"_\"> </span><span class=\"ff1 fc1 ws85\">DSST<span class=\"_ _58\"> </span></span><span class=\"ws0\">Comparison<span class=\"_ _59\"> </span>L<span class=\"_ _0\"></span>evel of Evidence</span>",
	"Brintellix_28ad2b93a0": "<span style=\"color: rgb(77, 127, 134); font-family: '15_VDWFON+AvenirNextLTPro-Demi';\"><font style=\"font-size: 25px;\">References</font></span>",
	"Brintellix_28e47bec84": "<font style=\"font-size: 15px; font-family: &quot;2_VDWFON+AvenirNextLTPro-Demi&quot;; color: rgb(100, 94, 94); line-height: 1.5;\"><b style=\"\">1.<br style=\"\">2.<br>3.<br>4.<br>5.<br>6.<br>7.<br>8.<br>9.</b></font>",
	"Brintellix_28e5df8a94": "<font style=\"font-size: 15px; font-family: &quot;3_BNJCUB+AvenirNextLTPro-Regular&quot;; color: rgb(100, 94, 94); line-height: 1.5;\">Jaeger J et al. Psych Res 2006;145:39-48.<br style=\"\">Greer T et al. CNS Drugs 2010;24:267-284.<br>McIntyre RS et al. Int J Neuropsychopharmacol 2014;17:1557-1567.<br>McIntyre RS et al. Int J Neuropsychopharmacol 2016;19:1-9.<br>Mahableshwarkar AR et al. Neuropsychopharmacol 2015;40:2025-2037.<br>Katona C et al. Int Clin Pyschopharmacol 2012;27:215-223.<br>Brintellix<sup style=\"line-height:0;\">®</sup> Summary of Product Characteristics. 2021.<br>Albinet CT et al. Brain Cogn 2012;79:1-11.<br>Lezak M. Neuropsychological Assessment. 3rd ed. New York: Oxford University Press. 1995.</font>",
	"Brintellix_28f10f30f3": "<span style=\"color: rgb(77, 127, 134); font-family: '1_WUORLG+AvenirNextLTPro-Bold'; font-size: 15px;\"><div style=\"text-align: center;\">Standardized effect size vs. placebo</div></span>",
	"Brintellix_2864ed220b": "<span style=\"color: rgb(100, 94, 94); font-family: '2_VDWFON+AvenirNextLTPro-Demi'; font-size: 15px;\"><div style=\"text-align: center;\">CONNECT study<sup style=\"font-size: 60%;\">5</sup></div></span>",
	"Brintellix_2801be4b6e": "<span style=\"color: rgb(100, 94, 94); font-family: '2_VDWFON+AvenirNextLTPro-Demi'; font-size: 15px;\"><div style=\"text-align: center;\">FOCUS study<sup style=\"font-size: 60%;\">3</sup></div></span>",
	"Brintellix_2809a48b93": "<span style=\"color: rgb(100, 94, 94); font-family: '2_VDWFON+AvenirNextLTPro-Demi'; font-size: 15px;\">ELDERLY study<sup style=\"line-height:0; font-size:60%;\">6</sup></span>",
	"Brintellix_28f27c2af2": "<span style=\"color: rgb(100, 94, 94); font-family: '2_VDWFON+AvenirNextLTPro-Demi'; font-size: 15px;\"><div style=\"text-align: center;\">Meta 3 studies</div></span>",
	"Brintellix_28677211b8": "<span style=\"color: rgb(100, 94, 94); font-family: '2_VDWFON+AvenirNextLTPro-Demi'; font-size: 15px;\"><div style=\"text-align: center;\">Meta 2 studies</div></span>",
	"Brintellix_28512db115": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Brintellix<sup style=\"line-height:0; font-size:60%;\">®</sup><br>10 mg/20 mg<br>Flex</span>",
	"Brintellix_28780d15ee": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Duloxetine</span>",
	"Brintellix_2850928f9b": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Brintellix<sup style=\"line-height:0; font-size:60%;\">®</sup><br>10 mg</span>",
	"Brintellix_28a6bb8ec8": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Brintellix<sup style=\"line-height:0; font-size:60%;\">®</sup><br>20 mg</span>",
	"Brintellix_28667c1feb": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Brintellix<sup style=\"line-height:0; font-size:60%;\">®</sup><br>5 mg</span>",
	"Brintellix_2861497b4f": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Duloxetine</span>",
	"Brintellix_28ca61967a": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Brintellix<sup style=\"line-height:0; font-size:60%;\">®</sup></span>",
	"Brintellix_280bf51d43": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Duloxetine</span>",
	"Brintellix_28590d5df2": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Brintellix<sup style=\"line-height:0; font-size:60%;\">®</sup></span>",
	"Brintellix_281beb6c81": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 14px;\">Duloxetine</span>",
	"Brintellix_2882c37cf9": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 13px;\">Indirect effect (correlated with MADRS)</span>",
	"Brintellix_28623a923c": "<span style=\"color: rgb(100, 94, 94); font-family: '3_BNJCUB+AvenirNextLTPro-Regular'; font-size: 13px;\">Direct effect (not correlated with MADRS)</span>",
	"Brintellix_28e56e8b58": "<div style=\"line-height: 1.3;\"><div style=\"\"><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">*As measured by DSST. The DSST provides a measure of key cognitive processes such as executive function, working memory, processing speed and&nbsp;</font></span><span style=\"font-family: &quot;3_BNJCUB+AvenirNextLTPro-Regular&quot;; font-size: 11px; color: rgb(100, 94, 94);\">visuo-spatial attention.</span></div><div><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">**p&lt;0.05; ***p&lt;0.01; †p&lt;0.001 vs. placebo.</font></span></div><div><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">Total, direct, and indirect effects of Brintellix<sup style=\"line-height:0;\">®</sup> and duloxetine on DSST adjusted for change from baseline in MADRS score (path analysis). Numbers above&nbsp;</font></span><span style=\"font-family: &quot;3_BNJCUB+AvenirNextLTPro-Regular&quot;; font-size: 11px; color: rgb(100, 94, 94);\">bars are standardised total effect size vs. placebo. P-values refer to results from unmediated ANCOVA model that did not include change in MADRS.</span></div><div><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">Meta 3 studies: meta-analysis based on Mahableshwarkar AR et al. 2015, Mcintyre RS et al. 2014, and Katona C et al. 2012. Meta 2 studies: meta-analysis based on Mahableshwarkar AR et al. 2015 and Katona C et al. 2012.</font></span></div><div><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">Duloxetine was included as an active reference in the CONNECT and ELDERLY studies for study validation, not for comparison of effect sizes. DSST scores were assessed as a predefined primary outcome of CONNECT, part of a composite primary outcome of FOCUS, and an exploratory outcome of the ELDERLY study, with path analysis performed post hoc. Clinical relevance is indicated by the orange line at 0.2 on the Y-axis.</font></span></div><div><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">In the CONNECT and FOCUS trials, Brintellix<sup style=\"line-height:0;\">®</sup> demonstrated improvements on aspects of cognitive performance, as assessed by DSST, that are largely&nbsp;</font></span><span style=\"font-family: &quot;3_BNJCUB+AvenirNextLTPro-Regular&quot;; font-size: 11px; color: rgb(100, 94, 94);\">independent of its effect on mood, as measured by MADRS.</span></div><div><span style=\"color: rgb(100, 94, 94);\"><font style=\"font-size: 11px;font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\">ANCOVA, analysis of covariance; DSST, Digit Symbol Substitution Test; MADRS, Montgomery-Åsberg Depression Rating Scale.</font></span></div></div>",
	"Brintellix_280baca441": "<span style=\"color: rgb(77, 127, 134); font-family: '1_WUORLG+AvenirNextLTPro-Bold'; font-size: 22px;\">Digit Symbol Substitution Test (DSST)<sup style=\"line-height:0; font-size:60%;\">1</sup></span>",
	"Brintellix_2816b06c98": "<div style=\"line-height: 1.3;\"><div style=\"\"><font style=\"font-size: 17px; font-family: &quot;15_VDWFON+AvenirNextLTPro-Demi&quot;; color: rgb(100, 94, 94);\">The DSST provides an objective measure of key cognitive processes such as executive function, working memory, processing speed and visuo-spatial attention </font></div></div>",
	"Brintellix_2877fa785b": "<div style=\"text-align: center;\"><span style=\"color: rgb(255, 255, 255);font-size: 19px; font-family: '1_WUORLG+AvenirNextLTPro-Bold';\"><b style=\"font-family: '1_WUORLG+AvenirNextLTPro-Bold';\">Executive<br>function</b></span></div>",
	"Brintellix_28784d1794": "<div style=\"text-align: center;\"><span style=\"color: rgb(255, 255, 255);font-size: 19px; font-family: '1_WUORLG+AvenirNextLTPro-Bold';\"><b style=\"font-family: '1_WUORLG+AvenirNextLTPro-Bold';\">Processing<br>speed</b></span></div>",
	"Brintellix_28e940f8a8": "<div style=\"text-align: center;\"><span style=\"color: rgb(255, 255, 255);font-size: 19px; font-family: '1_WUORLG+AvenirNextLTPro-Bold';\"><b style=\"font-family: '1_WUORLG+AvenirNextLTPro-Bold';\">Attention</b></span></div>",
	"Brintellix_28c9669fff": "<div style=\"text-align: center;\"><span style=\"color: rgb(255, 255, 255);font-size: 19px; font-family: '1_WUORLG+AvenirNextLTPro-Bold';\"><b style=\"font-family: '1_WUORLG+AvenirNextLTPro-Bold';\">Working<br>memory</b></span></div>",
	"Brintellix_286c2c9238": "<span style=\"color: rgb(100, 94, 94);font-size: 11px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';\"><b style=\"font-family: '1_WUORLG+AvenirNextLTPro-Bold';\">1.</b> Albinet CT et al. Brain Cogn 2012;79:1-11.&nbsp;</span>",
	"Brintellix_2870af603c": "Text",
	"Brintellix_288fb73aec": "",
	"Brintellix_28df28fec8": "",
	"Brintellix_280ab40e12": "",
	"Brintellix_280c6fc568": "",
	"Brintellix_28404b2dbb": "",
	"Brintellix_2876fce016": "",
	"Brintellix_28fbd870c8": "",
	"Brintellix_28edc11394": "",
	"Brintellix_28169a5fc6": "Text",
	"Brintellix_2876b8db1e": "Text",
	"Brintellix_288d2ce757": "Text",
	"Brintellix_286e71edc4": "Text",
	"Brintellix_2840daeebd": "Text",
	"Brintellix_28adb72b44": "Text",
	"Brintellix_281be2acc7": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;color: #4d7f86;\"><span style=\"color: #fff;\">Cognitive Symptoms</span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Functionality&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Motivation &amp; Energy&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Goal Attainment</div>"
}
